🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

8 results for “urea” Clear

  1. ANAGRELIDE HYDROCHLORIDE MONOHYDRATE, PEGINTERFERON ALFA-2A, MK-3543, BUSULFAN, MK-3543, RUXOLITINIB, MK-3543, MK-3543, RUXOLITINIB, PEGINTERFERON ALFA-2A

    Merck Sharp and Dohme

    Essential Thrombocythemia patients who have an inadequate response to or are intolerant of hydroxyurea

    phase 3 small molecule active

    1 trial

  2. Hydroxyurea

    Sana Biotechnology

    Thalassemia, Beta

    phase 2 small molecule active

    1 trial

  3. Triamcinolone Acetonide Acetate and Urea Cream.

    INTEGRATED BIOPHARMA INC

    Psoriasis Vulgaris

    phase 2 small molecule active

    1 trial

  4. 15NH4Cl, Sodium Chloride for injection, [13C]Sodium Acetate, CMP-CPS-001

    Camp4 Therapeutics Corp

    Urea cycle disorders (UCD)

    phase 1 small molecule active

    1 trial

  5. PYTEST® 14C-Urea Breath Test

    Phathom Pharmaceuticals

    H Pylori Infection

    approved small molecule active

    1 trial

  6. PYTEST® 14C-Urea Capsule Breath Test (at Home)

    Phathom Pharmaceuticals

    H. Pylori Infection

    approved small molecule active

    1 trial

  7. Saussurea Involucrata Liquid Tonic

    China SXT Pharmaceuticals

    Postpartum Rheumatism

    approved small molecule active

    1 trial

  8. Hydroxyurea

    United Therapeutics Europe Ltd

    Thrombocythemia

    small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources